Develops biomarkers of immunovascular dysfunction and cerebral small-vessel disease across neurodegenerative conditions.

Studies how systemic inflammation, innate immune activation, cellular senescence, and neurovascular-unit injury contribute to disease and uses extracellular-vesicle and biofluid approaches to improve diagnosis and identify therapeutic targets.